Dr Dai-Keller is a trained epidemiologist in chronic disease prevention and management, with a passion for identifying sensible and safe interventions to improve well-being in population health. Her research areas focus on studying the role of lifestyle and clinical risk factors for disease prevention, assessing biases in research design, methods, and dissemination, and evaluating the effectiveness and safety of medication use and diagnostic testing in clinical practice. 

Here at the Centre for Health Systems and Safety Research, she uses real-world big data from hospitals and the healthcare systems to evaluate the use of telemedicine and pathology testing in general practice and study their impacts on patient health outcomes and satisfaction, particularly before, during, and post COVID-19. 

Before joining Macquarie, she was a postdoctoral research fellow at The University of Sydney, where she assessed public health and clinical guidelines to address ways to improve elements on evidence base and patient orientation in the process of formulating guideline recommendations. After her PhD in Epidemiology at National University of Singapore, she was awarded a prestigious NIH T32 training grant in the U.S. as a postdoctoral fellow at Boston University, to study dietary and other lifestyle risk factors for musculoskeletal conditions in older adults.

Since her PhD, she has led several large population-based cohorts in Singapore, the U.S., and Australia with a focus on healthy ageing. Dr. Dai-Keller’s research has been covered in mass media, including the New York Times and Reuters. As an early career researcher, she received twice the Young Investigator Award from the International Osteoporosis Foundation.

Besides research, she enjoys teaching public health and mentoring HDR students to explore research ideas and discover new knowledge. She loves travelling around the world.